Braizon Therapeutics

About:

Braizon Therapeutics is a bio-venture firm originating from the University of Tokyo and Tokyo Medical and Dental University.

Website: https://braizon.com

Twitter/X: Braizon_en

Top Investors: SMBC Venture Capital, UTokyo Innovation Platform, Fast Track Initiative, Inc.

Description:

Braizon Therapeutics, Inc. was established with the aim of applying and implementing, within the fields of medicine and life science, innovative technology for the delivery of drugs to the brain as the outcome of collaborative research by Professor Kazunori Kataoka from the Graduate School of Engineering/Medicine, the University of Tokyo and Professor Takanori Yokota from the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.